Cargando…
Importance of Transparency in Assessing the Feasibility of Modeling Rare Disease
Autores principales: | Johnson, Scott J., Davis, Matthew R., Wang, Si-Tien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361492/ https://www.ncbi.nlm.nih.gov/pubmed/25505051 http://dx.doi.org/10.1177/0272989X14563081 |
Ejemplares similares
-
Near-death experiences and the importance of transparency in subjectivity,
ontology and epistemology
por: Stripp, Tobias Kvist
Publicado: (2021) -
Response to: Near-death experiences and the importance of transparency in
subjectivity, ontology and epistemology
por: Kondziella, Daniel, et al.
Publicado: (2022) -
Disease monitoring programs of rare genetic diseases: transparent data sharing between academic and commercial stakeholders
por: Lochmüller, Hanns, et al.
Publicado: (2021) -
Evidence and Transparency are Needed to Develop a Frontline Health Worker mHealth Assessment Platform
por: Ansermino, J. Mark, et al.
Publicado: (2019) -
The Bayesian Model on Human Papillomavirus Vaccination in Italy Lacks Transparency
por: Garattini, Livio, et al.
Publicado: (2013)